Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CEACAM16 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.003 |
mRNA | GPRIN3 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.003 |
mRNA | ZNF562 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.003 |
mRNA | NFYA | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | TMEM246 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | MYC | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | RPL22L1 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.003 |
mRNA | RBMX2 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.003 |
mRNA | ODF2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | EPDR1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |